GLAM
ARRY

Gardner Lewis Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Gardner Lewis Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-421,900
Closed -$19.5M – 101
2019
Q2 		$19.5M Buy
+421,900
New +$11.8M 2.4% 14

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Gardner Lewis Asset Management's ARRY Position: Q3 2019 in Review

Gardner Lewis Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 421,900 shares — an estimated $19.5M sold.

Gardner Lewis Asset Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $19.5M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Gardner Lewis Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 421,900 Array Biopharma Inc shares in Q3 2019, an estimated $19.5M.
  • Gardner Lewis Asset Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Array Biopharma Inc position peaked at $19.5M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Gardner Lewis Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.